Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high25.150 08/11/16
52 week low12.030 18/09/17
52 week change -9.250 (-41.11%)
4 week volume2,043,522 23/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Grant of Stock Options

RNS Number: 8182Q Venn Life Sciences Holdings PLC 14 September 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Grant of Stock Options to Directors and Management Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to...

Venn Life Sciences swings to operating profit

Venn Life Sciences swung to an operating profit of 0.01m, up from a loss of 0.03m in the first half of 2017. FINANCIAL H...

Half-year Report

RNS Number: 4324Q Venn Life Sciences Holdings PLC 12 September 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Half-year Report Interim Results for 6 months ended 30 June 2017 Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and re...

Senior Management Appointment

RNS Number: 9357L Venn Life Sciences Holdings PLC 25 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Senior Management Appointment Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechn...

Venn Life Sciences reports strong start to 2017

Venn Life Sciences announced the new financial year started well with contract wins of 5.7m secured in January and Feb...

Half year end update

RNS Number: 5675L Venn Life Sciences Holdings PLC 20 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Half year end update Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and m...

Result of AGM

RNS Number: 4690D Venn Life Sciences Holdings PLC 26 April 2017 26 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Result of Annual General Meeting Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to phar...

Proposed amendment to AGM resolution

RNS Number: 3003D Venn Life Sciences Holdings PLC 25 April 2017 25 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") AGM update Proposed amendment to resolution to be considered at AGM Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial manag...

Latest discussion posts More

  • venn priced to fail

    Venn is priced to show annual falls in earnings over several years ie go nowhere or suddenly develop massive losses. That might be right or wrong I really don't know. But with ...
    10-Oct-2017
    conor00
  • Big move up today

    with barely any stock available to buy online. Just moved up another 0.38p on a single #1,400 buy :o)) Could be quite a dramatic rise in store if there's now such a shortage ...
    9-Oct-2017
    gretel
  • Interesting new interview

    with a VENN operations manager re their clinical trial ...
    1-Oct-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY23%
BT GROUP17%
AMINO TECH17%
AVIVA11%
21ST CENT TECH11%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN